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A 25 year-old woman with a history of having erythe-
matous macules and papules with a reticular pattern on 
her chest, spreading to the upper abdomen and neck for 
about three months has visited outpatient clinic for con-
sultation. She was in a good general condition and only 
complained of a mild pruritus within skin lesions. She 
tried topical steroids of moderate potency in the past 
to treat skin lesions; however, without a big success. She 
was otherwise healthy and took no other medications. 
Which diagnosis is most likely in our patient? 
A. Polymorphic light eruption
B. Seborrheic dermatitis
C. Prurigo pigmentosa
D. Reticular erythematous mucinosis
E. Livedo reticularis
See next page for answer.
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Answer: reticulAr erythemAtous 
mucinosis
Reticular erythematous mucinosis (REM) syndrome is 
a condition first described by Steigleder et al. [1] in 1974. Ho-
wever, the first description of the entity currently known as 
REM has been reported already by Perry et al. [2] in 1960 as 
a plaque-like form of cutaneous mucinosis. REM is a rare, 
chronic and persistent disorder that affects patients of all 
ages and both sexes, but most cases are middle-aged wo-
men. The aetiology of REM remains unknown. REM has been 
considered by some authors to be an idiopathic, primary 
form of cutaneous mucinosis, while by others as a disor-
der closely related to or associated with cutaneous lupus 
erythematosus, in particular with lupus erythematosus tu-
midus. Both diseases share common features such as the 
plaque-like clinical aspect of lesions, the lack of significant 
immune serological abnormalities, histology, and response 
to antimalarial drugs [3, 4]. Other disorders reported in as-
sociation with occasional cases of REM syndrome include 
malignancies (breast and rectal carcinoma, Hodgkin disease) 
and autoimmune disorders, including thyroid disease, dia-
betes mellitus and ulcerative colitis. There are some reports 
linking REM to hormonal factors such as contraceptive pills, 
pregnancy and menses [3]. Viruses may also play a causal 
role, but this is still controversial and not well documented 
in the literature [5]. The photosensitivity and photodistribu-
tion of skin lesions observed in many patients suggest that 
sun exposure may play a role in the pathogenesis of REM. 
However, the recent review of 25 cases has reported that 
sun exposure worsened or triggered REM in five patients, 
but also improved the disease in another four [3]. Thus, the 
role of sunlight remains controversial. Regarding our case, 
the patient admitted, that erythematous lesions improve 
in summer, despite a clearly photodistributed location of 
skin abnormalities.
Clinically, REM syndrome manifests as the persistent 
erythema in a reticular pattern and/or confluent erythema-
tous papules and plaques that lack scales or other surface 
changes. Skin lesions are typically located on the central area 
of the chest or on the upper back but may also spread to 
the upper abdomen. The arms, face, and abdomen are less 
frequently affected [6]. Mucous membranes, genitalia, and 
internal organs are not involved, but in 1977 Keczkes and 
Jadhav reported a case with gum involvement and cervical 
lymphadenopathy [7]. Most of the affected patients are 
asymptomatic. However, in 20–30 percent of cases pruritus 
is reported [8]. Slight burning sensation may also occur in 
some cases [3]. The clinical course is cyclic with remission 
and exacerbation [9].
A perivascular, and occasionally perifollicular, mononuclear 
cell infiltrate with increased dermal mucin deposition is a cha-
racteristic histologic feature. The epidermis appears normal. 
Direct immunofluorescence is usually negative for immuno-
globulins, fibrin, and complement, although a few cases of REM 
with positive direct immunofluorescence and granular deposits 
of immunoglobulin IgM and C3 have been reported [4]. 
There is no single evidence-based treatment for REM, 
but antimalarials should be considered as a first-line therapy. 
Hydroxychloroquine 200–400 mg daily is considered the 
treatment of choice [3, 4, 6]. Numerous treatment options 
for REM syndrome have been examined. Successful treat-
ment of REM syndrome with topical tacrolimus or pimecro-
limus has been reported [4, 10]. Another effective treatment 
option is pulsed-dye laser (PDL) [4, 11]. UVA-1 (340–400 nm) 
therapy [12] and UVB excimer lamp (308 nm) [13] also re-
present an effective alternative in the treatment of REM. To 
exclude photosensitivity, photoprovocation testing should 
be performed on the patient’s healthy back skin before 
proceeding with phototherapy. However, further studies 
on large case series are needed to evaluate the efficacy of 
available treatment options.
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